NSEOutcome of Board Meeting24 Aug 2026 · 24 Aug 2026, 06:58 pm
Outcome of Board Meeting
Gujarat Kidney And Super Speciality Limited · GKSL
✦ AI SummaryMgmt Change
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Outcome of Board Meeting held on August 24, 2026. The Board has appointed Mrs. (Dr) Disha Bharpoda as Additional Non-Executive Independent Director with effect from August 24, 2026. The details as required under Regulation 30 of the Listing Regulations are enclosed as Annexure A.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Outcome of Board Meeting held on August 24, 2026.
Attachments (1)
📄pdf
Download →
GKSL2025_24082026185840_Signed_Outcome_of_BM_24082026.pdf
View document text
Date: 24.08.2026
To, To,
BSE Limited National Stock Exchange of India Limited
Listing Department Listing Department “Exchange Plaza,”
Phiroze Jeejeebhoy Towers, C-1, Block G, Bandra – Kurla Complex,
25th Floor, Dalal Street, Bandra (E), Mumbai - 400 051
Mumbai - 400 001
Scrip Code: 544666
Sub.: Outcome of the Board Meeting held on August 24, 2026 (“Meeting”)
Dear Sir
Pursuant to Regulation 30 and other applicable Regulations of SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015, we wish to inform that the Board of
Directors of the Company at their meeting held on today i.e. Monday, 24th August, 2026
inter alia, consider and approved the following matter:
1. Appointment of Additional Director: The Board has appointed Mrs. (Dr) Disha Bharpoda
(DIN: 11897794) as Additional- Non Executive- Independent Director with effect from
24.08.2026
The details as required under Regulation 30 of the Listing Regulations read with SEBI
Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, SEBI
Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 and SEBI
Circular No. SEBI/HO/CFD/CFDPoD-2/CIR/P/2024/185 dated December 31, 2024
is enclosed as Annexure A
2. The Board of the Directors took note of the approval given by the Shareholders
via Postal ballot to the following resolution –
Resolution Type of approval
To consider and approve Variation in the Objects / terms Special Resolution
of utilisation of the Initial Public Offering (“IPO”) proceeds.
The Meeting commenced at 4:30 P.M. and concluded at 5 P.M.
You are requested to kindly take the same on record.
Thanking You.
For Gujarat Kidney and Super Speciality Limited
Pragnesh Bharpoda
Managing Director
DIN: 01033141
Date: 24.08.2026
To, To,
BSE Limited National Stock Exchange of India Limited
Listing Department Listing Department “Exchange Plaza,”
Phiroze Jeejeebhoy Towers, C-1, Block G, Bandra – Kurla Complex,
25th Floor, Dalal Street, Bandra (E), Mumbai - 400 051
Mumbai - 400 001
Scrip Code: 544666
Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 – Appointment of Additional Non-Executive
Independent Director
Dear Sir
Pursuant to Regulation 30 of the Listing Regulations, it is hereby informed that based on
the recommendation of the Nomination and Remuneration Committee of the Board, the
Board of Directors of the Company in its Meeting today, 24-08-2026, appointed Mrs. Disha
Bharpoda (DIN: 11897794) as an Additional Non-Executive Independent Director, not
liable to retire by rotation, for a first term of five consecutive years, subject to the approval
by the Members of the Company.
The appointment shall be subject to the approval of Members at the next Annual General
Meeting of the Company and compliance with Regulation 17(1C) and Regulation 25(2A) of
the Listing Regulations and the relevant provisions of the Companies Act, 2013 shall be
followed.
Details with respect to the said appointment as required under Regulation 30(6) read with
Para A (7) of Part - A of Schedule III of the SEBI Listing Regulations and SEBI Circular No.
SEBI/HO/CFD/CFD PoD1/P/CIR/2023/123 dated 13th July 2023 are provided in
Annexure A to this letter.
Kindly take the same on your records.
Thanking you,
For Gujarat Kidney and Super Speciality Limited
Pragnesh Bharpoda
Managing Director
DIN: 01033141
ANNEXURE A
Details with respect to appointment of Additional Non-Executive Independent Director
under Regulation 30(6) read with Para A (7) of Part A of Schedule III of the Listing
Regulations and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated
13th July 2023:
Appointment of Mrs. Disha Bharpoda as the Additional Non-Executive Independent
Director
S. No. Particulars Description
1 Reason for change viz. Appointment as an Additional Non-Executive
appointment, resignation, Independent Director, not liable to retire by
removal, death or otherwise rotation, for a first term of five consecutive years,
subject to the approval by the Members of the
Company.
2 Date of appointment/ 24.08.2026
resignation & term of
appointment.
3 Brief profile (in case of Mrs Disha Bharpoda has completed her MD in
appointment) Radiology from Baroda Medical College,
Maharaja Sayajirao University, Vadodara,
Guajrat in the year 2021. Thereafter she worked
as Senior Resident Doctor for 5 years and for last
one she has started her own Radiology Centre.
4 Disclosure of relationships Mrs Disha Bharpoda is not related to any
between directors (in case of Director of the Company
appointment of a director).
This is for your information and records.
For Gujarat Kidney and Super Speciality Limited
Pragnesh Bharpoda
Managing Director
DIN: 01033141